Fortrea Holdings (FTRE) Non-Current Assets (2022 - 2026)
Fortrea Holdings' (FTRE) quarterly Non-Current Assets came in at $1.8 billion in Q2 2026, down 4.47% on a YoY basis from $1.9 billion in Q2 2025, and down 0.59% quarter-over-quarter from $1.8 billion in Q1 2026.
Analysis
Fortrea Holdings (FTRE) Non-Current Assets (2022 - 2026) Analysis & Trends
Fortrea Holdings (FTRE) has reported Non-Current Assets for 5 consecutive years, with $1.8 billion the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Non-Current Assets fell 4.47% year-over-year to $1.8 billion; the trailing twelve-month figure through Jun 2026 stood at $7.2 billion (down 22.9% YoY), and the FY2025 full-year result was $1.8 billion, down 30.88% from the prior year.
- Non-Current Assets retreated to $1.8 billion in Q2 2026 per FTRE's latest filing, from $1.8 billion in the prior quarter.
- Across five years, Non-Current Assets topped out at $3.1 billion in Q2 2023 and bottomed at $1.8 billion in Q2 2026.
- Historically, Non-Current Assets has averaged $2.5 billion across 5 years, with a median of $2.7 billion in 2024.
- The sharpest annual moves came in 2023 and 2025: Non-Current Assets grew 1.34% in 2023, then slumped 33.12% in 2025.
- Over 5 years, Non-Current Assets stood at $3.0 billion in 2022, then rose by 1.34% to $3.1 billion in 2023, then declined by 14.63% to $2.6 billion in 2024, then tumbled by 30.88% to $1.8 billion in 2025, then fell by 1.5% to $1.8 billion in 2026.
- According to Business Quant data, Non-Current Assets over the past three periods registered $1.8 billion, $1.8 billion, and $1.8 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.06 Bn | 42.11 Bn | 1.44 Bn | 23.66 Bn |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn | 1.01 Bn |
| 3 | Charles River Laboratories International | 13.77 Bn | 13.62 Bn | 452.07 Mn | 6.00 Bn |
| 4 | Icon | 12.62 Bn | 11.69 Bn | 479.29 Mn | 12.65 Bn |
| 5 | Fortrea Holdings | 1.68 Bn | 1.51 Bn | 139.20 Mn | 1.79 Bn |
| 6 | Evotec SE | 661.34 Mn | 235.46 Mn | - | 982.30 Mn |
| 7 | Ginkgo Bioworks Holdings | 442.79 Mn | 358.26 Mn | 18.44 Mn | 657.51 Mn |
| 8 | Champions Oncology | 72.49 Mn | 72.62 Mn | 7.03 Mn | 7.77 Mn |
| 9 | MindWalk Holdings | 61.66 Mn | 53.38 Mn | 1.82 Mn | 3.76 Mn |
| 10 | VivoSim Labs | 1.47 Mn | 1.47 Mn | - | 621,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.79 Bn |
| Mar 31, 2026 | 1.80 Bn |
| Dec 31, 2025 | 1.82 Bn |
| Sep 30, 2025 | 1.82 Bn |
| Jun 30, 2025 | 1.88 Bn |
| Mar 31, 2025 | 2.15 Bn |
| Dec 31, 2024 | 2.63 Bn |
| Sep 30, 2024 | 2.73 Bn |
| Jun 30, 2024 | 2.68 Bn |
| Mar 31, 2024 | 3.04 Bn |
| Dec 31, 2023 | 3.08 Bn |
| Sep 30, 2023 | 3.06 Bn |
| Jun 30, 2023 | 3.12 Bn |
| Dec 31, 2022 | 3.04 Bn |